These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 2156298

  • 1. Genetic polymorphisms of drug metabolism.
    Meyer UA, Zanger UM, Skoda RC, Grant D, Blum M.
    Prog Liver Dis; 1990; 9():307-23. PubMed ID: 2156298
    [No Abstract] [Full Text] [Related]

  • 2. [Genetic polymorphism of oxidative drug metabolism. Therapeutic and toxicologic implications].
    Eichelbaum M.
    Internist (Berl); 1983 Mar; 24(3):117-27. PubMed ID: 6135670
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Polymorphic drug oxidation in humans.
    Eichelbaum M.
    Fed Proc; 1984 May 15; 43(8):2298-302. PubMed ID: 6714436
    [Abstract] [Full Text] [Related]

  • 6. Polymorphic drug metabolism.
    Relling MV.
    Clin Pharm; 1989 Dec 15; 8(12):852-63. PubMed ID: 2689060
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Knowledge about metabolic capacity is important in drug therapy].
    Alván G, Dahl ML.
    Lakartidningen; 1992 Feb 05; 89(6):382, 387-90. PubMed ID: 1738265
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Genetic polymorphism of the hepatic metabolism of drugs].
    Larrey D, Pessayre D, Benhamou JP.
    Gastroenterol Clin Biol; 1985 Feb 05; 9(6-7):522-31. PubMed ID: 3926587
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Polymorphic oxidation of debrisoquine and sparteine.
    Eichelbaum M.
    Prog Clin Biol Res; 1986 Feb 05; 214():157-67. PubMed ID: 3523506
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacogenetic polymorphism of drug metabolism.
    Paxton JW.
    N Z Med J; 1984 Aug 22; 97(762):567-9. PubMed ID: 6591031
    [No Abstract] [Full Text] [Related]

  • 15. Genetic polymorphisms in drug metabolism--its relevance to Asian populations.
    Lee EJ.
    Ann Acad Med Singap; 1991 Jan 22; 20(1):56-60. PubMed ID: 2029165
    [Abstract] [Full Text] [Related]

  • 16. Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes.
    Frye RF, Matzke GR, Adedoyin A, Porter JA, Branch RA.
    Clin Pharmacol Ther; 1997 Oct 22; 62(4):365-76. PubMed ID: 9357387
    [Abstract] [Full Text] [Related]

  • 17. [Drug metabolism by the cytochrome p-450 enzyme. Variability of polymorphisms and exogenous carriers].
    Kreutzkamp B.
    Med Monatsschr Pharm; 2006 Feb 22; 29(2):48-50. PubMed ID: 16506587
    [No Abstract] [Full Text] [Related]

  • 18. The impact of genetic polymorphisms in risk assessment of drugs.
    Poulsen HE, Loft S.
    Arch Toxicol Suppl; 1994 Feb 22; 16():211-22. PubMed ID: 8192584
    [No Abstract] [Full Text] [Related]

  • 19. Human cytochromes P450: evolution, catalytic activities and interindividual variations in expression.
    Gonzalez FJ, Gelboin HV.
    Prog Clin Biol Res; 1991 Feb 22; 372():11-20. PubMed ID: 1956910
    [No Abstract] [Full Text] [Related]

  • 20. Genetics of drug transformation.
    Kalow W.
    Clin Biochem; 1986 Apr 22; 19(2):76-82. PubMed ID: 3518992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.